Authors: JEWELL SD GIENAPP IE COX KL WHITACRE CC

Citation: Sd. Jewell et al., ORAL TOLERANCE AS THERAPY FOR EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND MULTIPLE-SCLEROSIS - DEMONSTRATION OF T-CELL ANERGY, Immunology and cell biology, 76(1), 1998, pp. 74-82

Authors: POPOVICH PG YU JY GIENAPP IE WHITACRE CC

Citation: Pg. Popovich et al., ORAL TOLERANCE IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) - EFFECTS ON MICROGLIAL ACTIVATION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1069-1069

Authors: WHITACRE CC GIENAPP IE MEYER A COX KL JAVED N

Citation: Cc. Whitacre et al., TREATMENT OF AUTOIMMUNE-DISEASE BY ORAL TOLERANCE TO AUTOANTIGENS, Clinical immunology and immunopathology, 80(3), 1996, pp. 31-39

Authors: MEYER AL BENSON JM GIENAPP IE COX KL WHITACRE CC

Citation: Al. Meyer et al., SUPPRESSION OF MURINE CHRONIC RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY THE ORAL-ADMINISTRATION OF MYELIN BASIC-PROTEIN, The Journal of immunology, 157(9), 1996, pp. 4230-4238

Authors: JAVED NH GIENAPP IE COX KL WHITACRE CC

Citation: Nh. Javed et al., EXQUISITE PEPTIDE SPECIFICITY OF ORAL TOLERANCE IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, The Journal of immunology, 155(3), 1995, pp. 1599-1605